|
End-of-day quote
Australian S.E.
2026-09-03
|
5-day change | 1st Jan Change | ||
| 0.0260 AUD | 0.00% |
|
+4.00% | -25.71% |
| 08-27 | Syntara Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 07-27 | Syntara Limited, Q4 2026 Earnings Call, Jul 28, 2026 |
Published on 04/30/2026 at 01:20 am EDT - Modified on 05/04/2026 at 08:36 am EDT
Presenter Speech
Matthew Wright (Attendees)
Welcome to the Syntara Investor Webinar and Q&A following announcements through the week regarding FDA feedback on the proposed Phase IIb trial of amsulostat
[
Select your edition
All financial news and data tailored to specific country editions
